At What Stage of Kidney Disease Should You See a Nephrologist?

Most clinical guidelines agree that you should see a nephrologist no later than when your kidney function drops below an estimated glomerular filtration rate (eGFR) of 30 mL/min, which corresponds to Stage 4 chronic kidney disease (CKD). But that threshold is a floor, not a ceiling. Several common situations, including rapidly declining kidney function, significant protein in the urine, or poorly controlled blood pressure despite multiple medications, should prompt a referral much earlier. The gap between what guidelines recommend and when patients actually reach a nephrologist’s office is wide, and the consequences of that gap are well documented.

The Stage 4 Threshold

Stage 4 CKD means your kidneys are working at roughly 15 to 29 percent of normal capacity. At this point, complications like anemia, bone disease, fluid retention, and dangerous shifts in blood chemistry become common enough that a kidney specialist’s involvement is considered essential. The rationale is straightforward: if kidney function continues to decline, you may eventually need dialysis or a transplant, and preparing for either takes time. A nephrologist at Stage 4 can plan the type of dialysis access you’ll need, evaluate you for transplant eligibility, and adjust medications that your kidneys can no longer handle safely.¹

This benchmark appears across multiple guideline sets. The American Diabetes Association recommends that people with diabetes be referred when eGFR falls below 30, and earlier UK guidelines from NICE used the same cutoff.² Your primary care doctor can manage earlier stages of CKD effectively in many cases, particularly when the kidney disease is stable and the main tasks are controlling blood pressure, managing blood sugar, and monitoring lab work. The tipping point comes when the disease is no longer stable or when the complexity of care exceeds what a generalist can reasonably handle.

Situations That Warrant Earlier Referral

An eGFR below 30 is far from the only reason to see a nephrologist. Updated guidelines, including the 2021 NICE recommendations, have moved toward a more nuanced approach that considers your individual risk of actually needing dialysis or a transplant within the next five years, rather than relying on a single lab number alone.³ Beyond that risk-based model, several red flags should trigger a referral regardless of your current eGFR:

Rapid eGFR decline: A sustained drop of 15 mL/min or more per year, or a sudden drop of more than 25 percent from your baseline, signals something beyond ordinary progression.
Heavy proteinuria: Large amounts of protein in the urine, particularly an albumin-to-creatinine ratio above roughly 300 mg/g, suggest significant kidney damage that benefits from specialist management.
Resistant hypertension: Blood pressure that stays high despite four or more medications at full doses is both a cause and consequence of kidney disease, and it accelerates kidney function loss.
Electrolyte problems: Persistently high potassium (above 5.5) or persistently low potassium (below 3.5) can be dangerous and often reflects kidney dysfunction that needs closer attention.
Unexplained blood in the urine: When combined with protein in the urine, hematuria may point to a glomerular disease that requires biopsy and specialized treatment.
Suspected genetic or rare kidney diseases: Conditions like polycystic kidney disease or Alport syndrome are managed differently from typical CKD.

The Spanish nephrology guidelines for diabetic kidney disease also flag renal anemia, defined as hemoglobin below about 10.5 g/dL despite adequate iron stores, as a reason for referral.² These triggers exist because waiting for eGFR to reach 30 would mean missing the window for intervention in situations where kidney damage is progressing unusually fast or is driven by a treatable cause.

The Special Case of Diabetes

Diabetes is the single leading cause of kidney failure worldwide, and the trajectory of diabetic kidney disease can be unpredictable. Some people with diabetes lose kidney function slowly over decades; others experience rapid declines, especially when blood sugar and blood pressure are poorly controlled. For this reason, guidelines for diabetic patients tend to cast a wider net for referral triggers.

Beyond the standard eGFR-below-30 threshold, the American Diabetes Association recommends prompt referral when there is uncertainty about whether the kidney disease is actually from diabetes or from something else, when management becomes complicated, or when kidney function is dropping quickly. An eGFR decline faster than 5 mL/min per year qualifies as rapid progression in this context.² Alarm signs that suggest a non-diabetic cause of kidney disease, such as the sudden appearance of large amounts of protein in someone who previously had none, active urinary sediment, or kidney disease without retinopathy, also warrant a specialist evaluation even at higher eGFR levels.

Resistant hypertension in people with diabetes deserves special mention. One study found that patients with type 2 diabetes and treatment-resistant high blood pressure had a roughly 30 percent higher risk of losing more than 30 percent of their kidney function compared to those whose blood pressure responded to medication.⁴ That kind of accelerated decline is exactly the situation where a nephrologist’s involvement can make the biggest difference.

What the Evidence Says About Early vs. Late Referral

The research on referral timing is remarkably consistent: people who see a nephrologist earlier do better on almost every measure that matters. A 2025 systematic review and meta-analysis found that patients referred early had about a third lower risk of dying from any cause compared to those referred late. That survival advantage showed up within the first six months after starting dialysis and persisted out to five years.⁵

An earlier systematic review found a similar pattern, with early referral cutting mortality odds roughly in half at both three months and five years after starting dialysis. Initial hospitalization was nearly nine days shorter in the early-referral group, a difference that wasn’t explained by other health factors like diabetes, heart disease, or blood pressure control.⁶ A separate study looking at outcomes over three years after dialysis initiation found that early referral independently lowered the risk of frequent hospitalizations by about 78 percent and improved survival, even after accounting for whether dialysis itself was started in a planned or emergency fashion.⁷

One of the most tangible benefits is in dialysis access preparation. People who arrive at a nephrologist early are far more likely to have a permanent access site, like a fistula or graft, created before they ever need dialysis. The 2025 meta-analysis found that early referral more than tripled the likelihood of having permanent access in place and cut emergency dialysis starts by more than 60 percent.⁵ Starting dialysis through a temporary catheter because there was no time to create a fistula carries higher infection risk and worse outcomes, so this preparation time is not a minor detail.

It is worth noting that one Australian registry study found that after accounting for deaths that occurred before patients ever reached dialysis, the simple early-versus-late distinction became less predictive of post-dialysis mortality. That study’s authors argued that comorbidity burden, cardiovascular disease, and Indigenous status were stronger predictors of outcomes than referral timing alone.⁸ This doesn’t undercut the broader evidence but does highlight that referral timing is one piece of a larger picture. A patient with severe heart failure and multiple other conditions has a prognosis shaped by much more than when they first met a kidney specialist.

Why So Many People Are Still Referred Late

Despite the evidence, late referral remains stubbornly common. The reasons are a mixture of system-level gaps, physician behavior, and the silent nature of kidney disease itself.

Kidney disease rarely causes symptoms until it is quite advanced. You can lose more than half your kidney function without feeling any different, which means there is no pain or fatigue nudging you or your doctor toward action. Traditional screening with serum creatinine alone is notoriously insensitive at detecting early-stage disease, and patients at high risk, particularly those with diabetes or hypertension, do not always receive routine urine testing for protein.⁹ Without those screening results, there is nothing to trigger a referral.

Patient demographics also play a role. A study of referral patterns found that older patients, certain minority populations, and people without obvious comorbidities were significantly more likely to be referred late. The absence of conditions like hypertension, diabetes, or coronary artery disease seemed to create a false sense of security. Paradoxically, the “healthier-looking” patients were the ones most at risk of falling through the cracks.¹⁰ The same study noted that patients primarily cared for by a general internist were more likely to be referred late compared to those seeing a family practitioner or another subspecialist, suggesting that referral habits vary by practice type.

A lack of awareness about CKD among both patients and providers contributes as well. Patients often do not know they have kidney disease, and doctors may underestimate the importance of early specialist involvement when kidney numbers are declining slowly.¹¹

How Age Complicates the Decision

The standard eGFR cutoffs were not designed with age in mind, and that creates real problems at both ends of the age spectrum. Kidney function naturally declines with aging, so a 75-year-old with an eGFR of 45 may be experiencing normal kidney senescence rather than true progressive kidney disease. Meanwhile, a 30-year-old with an eGFR of 55 has lost a much larger fraction of their expected kidney function and has decades of potential decline ahead. Using the same referral threshold for both patients doesn’t make sense.

Non-age-adapted criteria lead to overdiagnosis and unnecessary specialist referrals in the very elderly, where the risk of dying from something else far exceeds the risk of ever reaching dialysis. At the same time, these criteria ignore young patients with long life expectancies who could benefit enormously from early intervention.³ Risk-based tools like the Kidney Failure Risk Equation, which estimates the probability of needing dialysis or a transplant within five years based on age, sex, eGFR, and urine albumin, are increasingly being recommended as a more rational way to decide who actually needs a nephrologist’s attention.

For a younger person with even moderate CKD, the math tilts toward earlier referral. You have more years for the disease to progress, more to gain from slowing it down, and more time to benefit from interventions like transplant planning. For an 85-year-old with stable Stage 3b disease and no proteinuria, the risks of aggressive specialist care may outweigh the benefits, and good primary care management may be entirely sufficient.

Medication Safety as a Referral Trigger

One underappreciated reason to see a nephrologist is medication management. As kidneys lose function, they clear drugs more slowly, and the wrong dose of a common medication can cause serious harm. Certain painkillers, antibiotics, diabetes drugs, and blood pressure medications need to be adjusted or avoided entirely as kidney function declines. Patients with CKD are also at higher risk of further kidney injury from medications that are otherwise considered safe in people with normal kidneys.¹²

Your primary care doctor can handle many of these adjustments, but the complexity escalates as kidney function drops. By Stage 4, the number of medications that require dose changes or carry kidney-specific risks is high enough that a nephrologist’s review becomes valuable. If you’re taking a long list of medications and your eGFR is falling, asking your doctor whether a nephrology consult would help with medication safety is a reasonable step even if your lab numbers haven’t yet crossed the formal referral line.

The Financial Side of Timing

Early referral isn’t just better for your health; it costs the healthcare system less. A Korean prospective study found that total healthcare costs in the 12 months before starting dialysis were significantly lower in patients who had been referred to a nephrologist early, by roughly $2,500 per patient on average. Costs in the first month after dialysis initiation were also lower.¹³ The savings come from fewer emergency hospitalizations, fewer complications from poorly planned dialysis starts, and better overall disease management during the transition period.

A broader narrative review of the topic reached the same conclusion: that early referral and appropriate specialist management can reduce the financial burden on healthcare systems, in addition to improving clinical outcomes.¹⁴ If you’re navigating insurance barriers or prior authorization requirements for a nephrology referral, the economic evidence provides a compelling case that the system is saving money in the wrong place by delaying access.

Electronic Consults and Expanding Access

One practical barrier to seeing a nephrologist is simply getting an appointment. In many regions, wait times for nephrology are measured in months. A Canadian study found the median wait for a traditional nephrology clinic appointment was about four months.¹⁵ For someone with rapidly declining kidney function, a four-month wait can mean the difference between planned and emergency dialysis.

Electronic consultations, where your primary care doctor sends your records and lab work to a nephrologist for review without you needing an in-person visit, are filling part of this gap. In one large e-consult study, nearly half of all consultations were resolved without the patient needing to see the nephrologist in person. The nephrologist reviewed the case, provided management recommendations, and the primary care doctor carried them out.¹⁶ Another UK study found that e-consultations gave nephrologists better access to clinical information than paper referrals, helped primary care doctors feel more confident managing CKD in the community, and freed up clinic slots for patients with more complex needs.¹⁷

More nephrologist visits in the year before dialysis are independently associated with lower odds of an unplanned, urgent dialysis start.¹⁸ If geography or appointment availability makes frequent in-person visits difficult, asking your doctor about e-consult options can keep specialist input flowing even when face-to-face access is limited.

What You Can Do Right Now

If you have CKD or risk factors for it, the most useful thing you can do is know your numbers. Ask your doctor for your eGFR and your urine albumin-to-creatinine ratio at your next visit. If your eGFR is below 30, you should already be seeing a nephrologist. If it is between 30 and 60 but dropping steadily, or if you have protein in your urine, blood in your urine, hard-to-control blood pressure, or diabetes with any kidney involvement, bring up the possibility of a nephrology referral rather than waiting for your doctor to suggest it.

The research on early referral gives a clear message: the patients who fare best are the ones whose nephrologists had time to plan ahead. Whether that means creating a fistula, evaluating transplant options, adjusting medications, or simply monitoring the pace of decline more closely, the advantage comes from months and years of lead time, not from a last-minute rescue. If there is any doubt about whether you need a specialist, the evidence leans heavily toward going sooner.